Literature DB >> 28430073

Physicians Must Discuss Potential Long-Term Risks of Fecal Microbiota Transplantation to Ensure Informed Consent.

Eline M Bunnik1, Nikkie Aarts1, Lea Ann Chen2.   

Abstract

Mesh:

Year:  2017        PMID: 28430073     DOI: 10.1080/15265161.2017.1299816

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  7 in total

Review 1.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

Review 2.  Rejuvenating the human gut microbiome.

Authors:  Shanlin Ke; Scott T Weiss; Yang-Yu Liu
Journal:  Trends Mol Med       Date:  2022-06-30       Impact factor: 15.272

Review 3.  Orchestrating the fecal microbiota transplantation: Current technological advancements and potential biomedical application.

Authors:  Manisha Nigam; Abhaya Shikhar Panwar; Rahul Kunwar Singh
Journal:  Front Med Technol       Date:  2022-09-22

4.  An ecological framework to understand the efficacy of fecal microbiota transplantation.

Authors:  Yandong Xiao; Marco Tulio Angulo; Songyang Lao; Scott T Weiss; Yang-Yu Liu
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

Review 5.  The role of the brain-gut-microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders.

Authors:  Michael Ganci; Emra Suleyman; Henry Butt; Michelle Ball
Journal:  Brain Behav       Date:  2019-09-30       Impact factor: 2.708

6.  Knowledge, attitudes, ethical and social perspectives towards fecal microbiota transplantation (FMT) among Jordanian healthcare providers.

Authors:  Amal G Al-Bakri; Amal A Akour; Wael K Al-Delaimy
Journal:  BMC Med Ethics       Date:  2021-02-27       Impact factor: 2.652

7.  Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature.

Authors:  R E Ooijevaar; E van Nood; A Goorhuis; E M Terveer; J van Prehn; H W Verspaget; Y H van Beurden; M G W Dijkgraaf; J J Keller
Journal:  Microorganisms       Date:  2021-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.